Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical Trial.
Chuah CH, Chow TS, Hor CP, Cheng JT, Ker HB, Lee HG, Lee KS, Nordin N, Ng TK, Zaid M, Zaidan NZ, Abdul Wahab S, Adnan NA, Nordin N, Tee TY, Ong SM, Chidambaram SK, Mustafa M; Malaysian Favipiravir Study Group. Chuah CH, et al. Clin Infect Dis. 2022 Aug 24;75(1):e432-e439. doi: 10.1093/cid/ciab962. Clin Infect Dis. 2022. PMID: 34849615 Clinical Trial.
PICK-ing Malaysia's Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio.
Suah JL, Tok PSK, Ong SM, Husin M, Tng BH, Sivasampu S, Thevananthan T, Appannan MR, Muhamad Zin F, Mohd Zin S, Yahaya H, Rusli N, Ujang MF, Mohd Ibrahim H, Abdullah NH, Peariasamy KM. Suah JL, et al. Among authors: peariasamy km. Vaccines (Basel). 2021 Nov 24;9(12):1381. doi: 10.3390/vaccines9121381. Vaccines (Basel). 2021. PMID: 34960126 Free PMC article.
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Ab Rahman N, Lim MT, Lee FY, Lee SC, Ramli A, Saharudin SN, King TL, Anak Jam EB, Ayub NA, Sevalingam RK, Bahari R, Ibrahim NN, Mahmud F, Sivasampu S, Peariasamy KM; SAFECOVAC study group. Ab Rahman N, et al. Among authors: peariasamy km. Vaccine. 2022 Jul 30;40(32):4394-4402. doi: 10.1016/j.vaccine.2022.05.075. Epub 2022 Jun 3. Vaccine. 2022. PMID: 35667917 Free PMC article.
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
Low EV, Tok PSK, Husin M, Suah JL, Tng BH, Thevananthan T, Appannan MR, Yahaya H, Mohd Zin S, Muhamad Zin F, Sivasampu S, Peariasamy KM. Low EV, et al. Among authors: peariasamy km. JAMA Netw Open. 2022 Aug 1;5(8):e2226046. doi: 10.1001/jamanetworkopen.2022.26046. JAMA Netw Open. 2022. PMID: 35947381 Free PMC article.
44 results